The Phenotype of Circulating Follicular-Helper T Cells in Patients with Rheumatoid Arthritis Defines CD200 as a Potential Therapeutic Target
Figure 2
TFH cell subsets in RA. The % of TFH cells with Th1, Th2, or Th17 phenotypes was assessed through expression of the chemokine receptors CXCR3 and CCR6 (see text for details). SP: seropositive, SN: seronegative. Spots represent individual patients. Mean ± SEM are shown.